University of Michigan
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Michigan sits in the top decile of US sponsors by registered trial count (#19 of 15,742 sponsors by registered trial count).
University of Michigan: 1,327 sponsored US clinical trials, 179 recruiting.
University of Michigan sponsors 1,327 registered US clinical trials on ClinicalTrials.gov, 179 of them currently recruiting, and 971 completed. 94 of these trials are in Phase 3-4 (later-stage) and 159 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 15 trials.
Top-decile sponsor footprint
University of Michigan ranks in the top decile of sponsors by registered trial count (#19 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
971 of 1,083 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,327 total, page 18 of 27
Pain Control Using Neuromodulation in Patients Undergoing Definitive Chemoradiotherapy for Head and Neck Cancer
NCT02366611
Routine Post-Operative Supplemental Nutrition
NCT02297607
Comparing the Effectiveness of Two Dietary Interventions for Fecal Incontinence
NCT02828384
REACH OUT: to Reduce High Blood Pressure in the Emergency Department
NCT02301455
Safety and Health Intervention Project
NCT02152397
Developing an mHealth Application to Improve Cancer Chemotherapy Symptom Management
NCT02460822
Functional Differences in Effortful Control
NCT01993147
Neurobiological Effects of Light on MDD
NCT02940769
GI SPORE Colon Biosample Protocol
NCT02243267
Primary Care Clinician Commitments to Choosing Wisely®
NCT02247050
Validation of Sleep Apnea Screening Device
NCT02814227
Auditory-somatosensory Stimulation to Alleviate Tinnitus
NCT02974543
Assessing Alternative Approaches for Blood Pressure Control: A3BC Trial
NCT02110381
Transcutaneous Raman Spectroscope (TRS) Analyses of Diabetic Foot Ulcers
NCT02202668
Evaluating Use of a Farmers Market Incentive Program Among Low-Income Health Center Patients
NCT02558660
My Health Coach Study
NCT02201069
Improving Mental Health Outcomes: Building an Adaptive Implementation Strategy
NCT02151331
Implementing Health Plan-Level Care Management for Solo & Small Practices
NCT02041962
Impact of Behavioral Feeding Intervention on Parent-Child Attachment in Young Children
NCT02187952
Endogenous Opioid Activity and Affective State in Insulin Resistant Women
NCT02069379
Active Class Space Metabolic Benefits Study
NCT02831309
Why do Oral Contraceptives Prevent Ovarian Cancer?
NCT02155777
Optimizing Prevention of Healthcare-Acquired Infections After Cardiac Surgery (HAI)_2
NCT02073760
CVCTPlus: A Couples-Based Approach to Linkage to Care and ARV Adherence
NCT01772992
Tissue Procurement Protocol for Patients Undergoing Treatment for Early-Stage Breast Cancer
NCT02455882
Geriatric Out of Hospital Randomized Meal Trial in Heart Failure
NCT02148679
Non-Invasive Characterization in Cardiac Sarcoidosis
NCT02017522
Pharmacokinetic Study of Bupropion Hydrochloride Products With Different Release Patterns
NCT02078180
Early Auditory Referral in Primary Care
NCT03004937
Sepsis Trial of Early Physical Therapy Outside the ICU
NCT02159222
The Immunological Basis for Treatment Resistance to Anti-TNF Treatments
NCT01971346
Lithium Disilicate (CAD/CAM) Fixed Partial Dentures (FPD) Clinical Study
NCT03036566
Cholinergic Nicotinic Receptors and Cognition in PD
NCT02076295
Beneficial Effects of Quercetin in Chronic Obstructive Pulmonary Disease (COPD)
NCT01708278
Promoting Optimal Healing After Laceration Repair Study
NCT02055794
Sleep Enhancing Tools: Pilot Study
NCT02068703
Thoracotomy Closure Technique and Postoperative Pain Study: A Randomized Controlled Trial
NCT02063438
A Trial of a Comprehensive Breast Cancer Treatment Patient Decision Tool
NCT01840163
Improving Patient Decisions About Bariatric Surgery
NCT02364128
EoE(Eosinophilic Esophagitis)
NCT01999439
Efficacy of Amlexanox vs. Placebo in Type 2 Diabetic Patients
NCT01975935
Health & Culture Project: Cultural Factors Underlying Obesity in African-American Adolescents
NCT02938663
EEG/Event-related Brain Potential Risk Markers as Predictors and Outcomes of SUD Treatment in Adolescents
NCT02016378
Stress Reactivity Study in Adolescents
NCT03997149
Prospective Comparison of Indirect Pulp Therapy and Mineral Trioxide Aggregate Pulpotomy in Decayed Primary Molars
NCT02620826
Initial Human Validation of Simultaneous Dual-Tracer Cardiac PET Imaging
NCT02003456
Scleroderma ARFI Imaging of the Skin
NCT02006420
Non-Contrast Magnetic Resonance Angiography Assessment of Patients Referred for Transcatheter Aortic Valve Implantation
NCT02007967
NMES Efficacy on Patients With NBPP
NCT01999465
Breathing Exercises for Asthma
NCT02151422
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 79 |
| Phase 2 | 80 |
| Phase 3 | 25 |
| Phase 4 | 69 |
Therapeutic Areas
What is open in the University of Michigan pipeline
179 recruiting of 1,327 indexed (13% open); 971 completed (73%).
Phase mix: 94 late (III/IV) vs 159 early (I/II) (early-phase heavy).
Top condition: Depression (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Michigan: open-pipeline peers nationwide
Peers matched on 1,327 registered trials and 13% open enrollment, not the therapeutic-area sidebar.
University of Michigan sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,327 trials (± recruiting share)
- Eli Lilly and Company · 1,341 trials · 9% recruiting
- GlaxoSmithKline · 1,345 trials · 4% recruiting
- AstraZeneca · 1,285 trials · 12% recruiting
- University of Colorado, Denver · 1,283 trials · 21% recruiting
Sponsors near 13% open enrollment (± trial volume)
- Wayne State University · 13% recruiting · 163 trials
- Case Comprehensive Cancer Center · 14% recruiting · 407 trials
- Albany Medical College · 13% recruiting · 52 trials
- Taiho Oncology · 13% recruiting · 52 trials
Related
What to do with this University of Michigan page
1,327 registered trials is a research-attention snapshot, not an endorsement of University of Michigan or any single study.
- 179 of University of Michigan's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition University of Michigan studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Michigan pipeline card: 1,327 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.